Wellness and Fitness Services ·
Company Name AstraZeneca plc (AstraZeneca) Industry Sector Biopharmaceuticals (Biologics) Focuses on the development, manufacture and commercialisation of prescription medicines across a number of therapeutic areas, including: Oncology Cardiovascular, Renal & Metabolic Diseases (CVRM) Respiratory & Immunology (RI) Rare Diseases (RD) Vaccines & Immune Therapies Headquarters Global Headquarters: Cambridge, UK US Headquarters: Wilmington, Delaware, USA Slogan "What science can do." Chinese translation: "The power of science" or "Science creates the future". Overview of operations in the United States The United States is one of AstraZeneca's largest markets, accounting for approximately 40 per cent of its annual sales revenues R&D and manufacturing facilities in Maryland, Massachusetts, California and Texas Significant investment in U.S.-based clinical trials, manufacturing, and cell and gene therapy technologies Committed to investing over $50 billion by 2030 to build capacity and upgrade research facilities in the US Market Capitalisation & Size (by mid-2025) Global market capitalisation of over $200 billion Employees: over 85,000 (worldwide) Global revenues of more than $44 billion by 2024, of which approximately $18 billion will come from the U.S. market *** Translated with www.DeepL.com/Translator (free version) ***